Related Experiment Video
Updated: Apr 7, 2026
09:51
A Microfluidic Platform for High-throughput Single-cell Isolation and Culture
Published on: June 16, 2016
12.2K
A High Throughput Micro-Chamber Array Device for Single Cell Clonal Cultivation and Tumor Heterogeneity Analysis
Feng-Min Shen1, Lian Zhu1, Heng Ye1
1Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, 430072, P. R. China.
Scientific Reports
|July 8, 2015
Summary
A new high-throughput device enables efficient single-cell isolation and clonal cultivation for three weeks. This technology facilitates detailed tumor heterogeneity studies at the single-cell level, advancing cancer research.
Area of Science:
- Biotechnology
- Cell Biology
- Cancer Research
Background:
- Single-cell cloning is crucial for monoclonal antibody screening and understanding tumor heterogeneity.
- Existing methods may lack the throughput or long-term cultivation capabilities needed for comprehensive studies.
Purpose of the Study:
- To develop a high-throughput device for efficient single-cell isolation and clonal cultivation.
- To enable long-term single-cell culture for detailed tumor heterogeneity analysis.
- To establish a platform for drug screening and biomarker discovery.
Main Methods:
- Development of a novel device with 1400 lateral chambers for single-cell isolation.
- Long-term clonal cultivation of single cells for up to three weeks.
- Application of the device to analyze tumor cell morphology, growth rate, drug tolerance, and protein expression.
Main Results:
- The device successfully isolated single cells with high efficiency.
- Hundreds of clones were generated from a single device, enabling single-cell level analysis.
- Tumor heterogeneity was effectively examined, including drug tolerance and ABCG2 protein expression.
Conclusions:
- The developed device provides a powerful platform for high-throughput single-cell cloning and long-term cultivation.
- It significantly advances the study of tumor heterogeneity at the single-cell level.
- The platform holds promise for drug screening, biomarker discovery, and metastasis assays.
